<i>M. avium Complex</i> Pulmonary Infections: Therapeutic Obstacles and Progress in Drug Development

Worldwide, several million people are infected with mycobacteria such as <i>Mycobacterium tuberculosis</i> (<i>M. tb</i>) or non-tuberculous mycobacteria (NTM). In 2023, 10.8 million cases and 1.25 million deaths due to <i>M. tb</i> were recorded. In Europe and North America, the emergence of NTM is...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Elise Si Ahmed Charrier, Alexandra Dassonville-Klimpt, Claire Andréjak, Pascal Sonnet
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-06-01
Edice:	Pharmaceuticals
Témata:	non-tuberculous mycobacteria <i>Mycobacterium avium complex</i> anti-MAC compounds drug development clinical trials
On-line přístup:	https://www.mdpi.com/1424-8247/18/6/891
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!